Left atrial function assessed by trans-thoracic echocardiography in patients treated by ablation for a lone paroxysmal atrial fibrillation

European Journal of Echocardiography

Volumn 11, Issue 10, 2010, Pages 845-852

  Donal, Erwan ^a,b,c   Ollivier, Romain ^a,b,c   Veillard, David ^c   Hamonic, Stéphanie ^c   Pavin, Dominique ^a,b,c   Daubert, J Claude ^a,b,c   Mabo, Philippe ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Atrial fibrillation; Catheter ablation; Echocardiography; Remodelling; Strain; Strain rate; Tissue Doppler imaging

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HUMAN; MALE; PRIORITY JOURNAL; SYSTOLE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 78649353388     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jeq074     Document Type: Article

References (39)

1. Nattel S, Opie LH. Controversies in atrial fibrillation. Lancet 2006;367:262-72.
2. Heidbuchel H. A paradigm shift in treatment for atrial fibrillation: from electrical to structural therapy? Eur Heart J 2003;24:2077-8.
3. Manning WJ, Silverman DI, Katz SE, Gugliotta F, Vicedomini G, Gulletta S et al. Impaired left atrial mechanical function after cardioversion: relation to the dur-ation of atrial fibrillation.J Am Coll Cardiol 1994;23:1535-40.
4. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment ofsympto-matic atrial fibrillation: a randomized trial. JAMA 2005;293:2634-40.
5. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S et al. A ran-domized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.J Am Coll Cardiol 2006;48:2340-7.
6. Pappone C, Manguso F, Vicedomini G, Gugliotta F, Santinelli O, Ferro A et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004;109:327-34.
7. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein abla-tion for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.JAm Coll Cardiol 2003;42:185-97.
8. D'Andrea A, Caso P, Romano S, Scarafile R, Riegler L, Salerno G et al. Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. Eur Heart J 2007;28:2738-48.
9. Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello AR, Russo MG et al. Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 2005;112:387-95.
10. Donal E, Raud-Raynier P, Racaud A, Coisne D, Herpin D. Quantitative regional analysis of left atrial function by Doppler tissue imaging-derived parameters dis-criminates patients with posterior and anterior myocardial infarction. J Am Soc Echocardiogr 2005;18:32-8.
11. Boyd AC, Schiller NB, Ross DL, Thomas L Differential recovery of regional atrial contraction after restoration of sinus rhythm after intraoperative linear radiofre-quency ablation for atrial fibrillation. Am J Cardiol 2009;103:528-34.
12. Eshoo S, Boyd AC, Ross DL, Marwick TH, Thomas L. Strain rate evaluation of phasic atrial function in hypertension. Heart 2009;95:1184-91.
13. Thomas L. Assessment of atrial function. Heart Lung Circ 2007;16:234-42.
14. D'Andrea A, Caso P, Romano S, Scarafile R, Cuomo S, Salerno G et al. Associ-ation between left atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study. Int J Cardiol 2009;132:354-63.
15. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiol-ogy/American Heart Association Task Force on Practice Guidelines and the Euro-pean Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006;27:1979-2030. (Pubitemid 44313588)
16. Mattioli AV, Sansoni S, Lucchi GR, Mattioli G. Serial evaluation of left atrial dimen-sion after cardioversion for atrial fibrillation and relation to atrial function. Am J Cardiol 2000;85:832-6.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quanti-tation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
18. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echo-cardiography. Eur J Echocardiogr 2009;10:165-93.
19. Hanna N, Cardin S, Leung TK, Nattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 2004;63:236-44.
20. Verheule S, Sato T, Everett T IV, Engle SK, Otten D, Rubart-von der Lohe M. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression ofTGF-beta1. Circ Res 2004;94:1458-65.
21. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN et al. Detec-tion and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrilla-tion. Circulation 2009;119:1758-67.
22. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999;100:87-95.
23. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79.
24. Nattel S, Shiroshita-Takeshita A, Cardin S, Pelletier P. Mechanisms of atrial remo-deling and clinical relevance. Curr Opin Cardiol 2005;20:21-5.
25. Lim TK, Dwivedi G, Hayat S, Majumdar S, Senior R. Independentvalue of left atrial volume index for the prediction of mortality in patients with suspected heart failure referred from the community. Heart 2009;95:1172-8.
26. Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L et al. Left atrial remodelling in patients with myocardial infarction complicated by heart failure left ventricular dysfunction, or both: the VALIANT Echo study. Eur Heart J 2009; 30:56-65.
27. Thomas L, Hoy M, Byth K, Schiller NB. The left atrial function index: a rhythm independent marker of atrial function. Eur J Echocardiogr 2008;9:356-62.
28. Caso P, Ancona R, Di Salvo G, Comenale Pinto S, Macrino M, Di Palma V et al. Atrial reservoir function by strain rate imaging in asymptomatic mitral stenosis: prognostic value at 3 year follow-up. Eur J Echocardiogr 2009;10:753-9.
29. Kaya EB, Tokgözoglu L, Aytemir K, Kocabas U, Tülümen E, Deveci OS et al. Atrial myocardial deformation properties are temporarily reduced after cardioversion for atrial fibrillation and correlate well with left atrial appendage function. Eur J Echocardiogr 2008;9:472-7.
30. Chan MY, Wong HB, Ong HY, Yeo TC. Prognostic value of left atrial size in chronic kidney disease. Eur J Echocardiogr 2008;9:736-40.
31. Lo LW, Tai CT, Lin YJ, Chang SL, Udyavar AR, Hu YF et al. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: impli-cations for catheter ablation strategy and long-term outcome. Heart Rhythm 2009;6:311-8.
32. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR et al. Pre-diction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?J Am Coll Cardiol 2006;47:1018-23.
33. Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG, Bailey KR et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001;76:467-75.
34. Yu CM, Fang F, Zhang Q, Yip GW, Li CM, Chan JY et al. Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure.J Am Coll Cardiol 2007;50:778-85.
35. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incre-mental prognostic value.J Am Coll Cardiol 2003;41:820-6.
36. Donal E, Raud-Raynier P, De Place C, Gervais R, Rosier A, Roulaud M et al. Resting echocardiographic assessments of left atrial function and filling pressure interest in the understanding of exercise capacity in patients with chronic conges-tive heart failure. J Am Soc Echocardiogr 2008;21:703-10.
37. Modesto KM, Dispenzieri A, Cauduro SA, Lacy M, Khandheria BK, Pellikka PA et al. Left atrial myopathy in cardiac amyloidosis: implications of novel echocardio-graphic techniques. Eur Heart J 2005;26:173-9.
38. Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP et al. Valsar-tan for prevention ofrecurrent atrial fibrillation. N Engl J Med 2009;360:1606-17.
39. Asher CR, Klein AL. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update. Card Electrophysiol Rev 2003;7: 387-91.